Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 6/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.31 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1664032 | 0.71 | HTR6 (0.32) | — | |
| SCHEMBL27817134 | 0.69 | HTR6 (0.31) | — | |
| SCHEMBL757569 | 0.68 | — | — | |
| SCHEMBL6302024 | 0.68 | KDM1A (0.36) | — | |
| SCHEMBL8909200 | 0.68 | — | — | |
| SCHEMBL11458282 | 0.67 | PARP1 (0.36) | — | |
| SCHEMBL7538817 | 0.62 | ACHE (0.38) | MAOAMAOBACHE | |
| SCHEMBL11782467 | 0.62 | S100A4 (0.34) | MAOBACHE | |
| SCHEMBL27777611 | 0.62 | — | — | |
| SCHEMBL989079 | 0.62 | IDO1 (0.39) | MAOAMAOBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2025-01-30 | — | — | US | claimed |
| EP-4458805-A1 | CATIONIC LIPID CONTAINING FUNCTIONAL GROUP ON SIDE CHAIN, AND USE THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2024-11-06 | — | — | EP | claimed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | claimed |
| WO-2020126442-A1 | ONE-PART PHOTOCURABLE (METH) ACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2020-06-25 | — | — | WO | claimed |
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2020-05-26 | — | — | US | claimed |
| US-10434182-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2019-10-08 | — | — | US | claimed |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2018-08-02 | — | — | US | claimed |
| EP-3315531-A1 | 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2018-05-02 | — | — | EP | claimed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | claimed |
| CN-106397130-A | Preparation method for 5-hydroxyl-5-phenylacetylene dibenzosuberenone | 上海博康精细化工有限公司 | 2017-02-15 | — | — | CN | claimed |
| CN-104529898-B | Azepine dibenzo cyclooctyne compounds and preparation method thereof | 成都丽凯手性技术有限公司 | 2016-07-27 | — | — | CN | claimed |
| EP-2665700-B1 | ONE-POT PREPARATION OF CYCLOBENZAPRINE HYDROCHLORIDE | HARMAN FINOCHEM LTD (IN) | 2016-01-13 | — | — | EP | claimed |
| CN-104877127-A | Eight-armed polyethylene glycol derivative, preparation method and related biological substance modified by derivative | XIAMEN SINOPEG BIOTECH CO LTD | 2015-09-02 | — | — | CN | claimed |
| CN-104529898-A | Heterocyclic nitrogen-dibenz-cyclooctyne class compound and preparation method thereof | CHENGDU LIKAI CHIRAL TECHNOLOGY CO LTD | 2015-04-22 | — | — | CN | claimed |
| US-20090220436-A1 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | LIVING PROOF, INC. (US) | 2009-09-03 | — | — | US | claimed |
| WO-2007127065-A9 | IN SITU POLYMERIZATION FOR HAIR TREATMENT | ANDORA INC (US) | 2008-07-31 | — | — | WO | claimed |
| WO-2007134219-A2 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | LIVING PROOF, INC. (US) | 2007-11-22 | — | — | WO | claimed |
| WO-2007127065-A2 | IN SITU POLYMERIZATION FOR HAIR TREATMENT | LIVING PROOF, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| EP-4737504-A2 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-4489090-A | ATHEROSCLEROSIS | AMERICAN CYANAMID COMPANY (US) | 1984-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10434182-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, MRPS18A | ANPEP 2341/4885MAOA 3971/4885MAOB 3626/4885 |
| US-10660969-B2 | Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof | MRPL38, ALG8, COG8 | ANPEP 2153/4885MAOA 3307/4885MAOB 3525/4885 |
| US-20180214561-A1 | EIGHT-ARM POLYETHYLENE GLYCOL DERIVATIVE, PRODUCTION METHOD THEREFOR, AND MODIFIEDBIO-RELATEDSUBSTANCETHEREOF | MRPL38, CXCL8, ALG8 | ANPEP 3139/4885MAOA 3948/4885MAOB 1917/4885 |
| US-20090220436-A1 | IN SITU POLYMERIZATION FOR SKIN TREATMENT | CUTA, ESD, PFAS | ANPEP 2025/4885MAOA 140/4885MAOB 386/4885 |
| US-20250034080-A1 | CATIONIC LIPID CONTAINING SIDE-CHAIN FUNCTIONAL GROUPS AND APPLICATION THEREOF | PHOSPHO1, LIPA, SLC7A1 | ANPEP 1502/4885MAOA 3493/4885MAOB 2680/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | ANPEP 2900/4885MAOA 3271/4885MAOB 2760/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | ANPEP 2900/4885MAOA 3271/4885MAOB 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.